Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05734989 · ClinicalTrials.gov registry record
Improving Screening and Therapy for Hispanic/Latinx at Risk for CKD
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 248
- Enrollment target
NCT05734989 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 248 participants.
The verdict
NCT05734989 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 248 participants
- Enrollment target
Study Summary
In Aim 1 of this study, the investigators will utilize community organizations to screen Hispanics/Latino(a)s for kidney disease, diabetes, and other risk factors, and refer them for care with a PCP. In Aim 2, the investigators will implement an intervention in local health clinics to assist PCPs with screening and treating Hispanic and Black patients with diabetes. Completion of the project will hopefully slow progression of kidney disease among Hispanic/Latino(a) and Black patients in Durham, and the information gained will allow the investigators to eventually perform the intervention on a larger scale.
Interventions
- DIAGNOSTIC_TEST BP
- DIAGNOSTIC_TEST HbA1c
- BEHAVIORAL PCP Guidelines for Screening and Monitoring Hispanic/Latinx patients for CKD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 248 participants |
| Start Date | 2023-05-18 |
| Est. Completion | 2025-04-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05734989
The ClinicalTrials.gov registry entry for NCT05734989 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 248 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which BP is the first listed.
NCT05734989 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05734989 about?
NCT05734989 is a clinical study titled "Improving Screening and Therapy for Hispanic/Latinx at Risk for CKD". In Aim 1 of this study, the investigators will utilize community organizations to screen Hispanics/Latino(a)s for kidney disease, diabetes, and other risk factors, and refer them for care with a PCP. In Aim 2, the investigators will implement an intervention in local health clinics to assist PCPs w...
What is the current status of trial NCT05734989?
This trial is currently completed. The enrollment target is 248 participants. The study started on 2023-05-18. Estimated completion is 2025-04-04.
What interventions are being tested in trial NCT05734989?
The interventions under investigation include: BP (DIAGNOSTIC_TEST), HbA1c (DIAGNOSTIC_TEST), PCP Guidelines for Screening and Monitoring Hispanic/Latinx patients for CKD (BEHAVIORAL).
Who is sponsoring clinical trial NCT05734989?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.